Deutsche Bank’s BioAtla BCAB Stock Holding History

Deutsche Bank’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$84.1K	Hold	10,507	–	–	﹤0.01%	3334
2025 Q4	$299K	Hold	10,507	–	–	﹤0.01%	2827
2025 Q3	$362K	Hold	10,507	–	–	﹤0.01%	2721
2025 Q2	$210K	Hold	10,507	–	–	﹤0.01%	2944
2025 Q1	$184K	Hold	10,507	–	–	﹤0.01%	2987
2024 Q4	$310K	Hold	10,507	–	–	﹤0.01%	2891
2024 Q3	$925K	Sell	10,507 -13,400	-56%	-$1.12M	﹤0.01%	2157
2024 Q2	$1.64M	Sell	23,907 -978	-4%	-$116K	﹤0.01%	1735
2024 Q1	$4.28M	Buy	24,885 +2,381	+11%	+$296K	﹤0.01%	1335
2023 Q4	$2.77M	Buy	22,504 +16,922	+303%	+$1.47M	﹤0.01%	1507
2023 Q3	$475K	Sell	5,582 -8,266	-60%	-$1.05M	﹤0.01%	2206
2023 Q2	$2.08M	Hold	13,848	–	–	﹤0.01%	1601
2023 Q1	$1.86M	Buy	13,848 +5,876	+74%	+$1.06M	﹤0.01%	1729
2022 Q4	$3.29M	Buy	7,972 +2,000	+33%	+$830K	﹤0.01%	1399
2022 Q3	$2.3M	Buy	5,972 +3,000	+101%	+$982K	﹤0.01%	1558
2022 Q2	$424K	Sell	2,972 -659	-18%	-$105K	﹤0.01%	2706
2022 Q1	$908K	Sell	3,631 -19	-0.5%	-$7.95K	﹤0.01%	2412
2021 Q4	$3.58M	Sell	3,650 -43	-1%	-$55K	﹤0.01%	1628
2021 Q3	$5.44M	Sell	3,693 -3,759	-50%	-$7.32M	﹤0.01%	1457
2021 Q2	$15.8M	Buy	7,452 +7,298	+4,739%	+$16.5M	0.01%	992
2021 Q1	$391K	Buy	+154	New	+$395K	﹤0.01%	3248

Other funds holding BCAB

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Deutsche Bank's BCAB Position: Q1 2026 in Review

Deutsche Bank held its BioAtla (BCAB) position steady in Q1 2026 at 10,507 shares worth $84.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3334.

Deutsche Bank first reported a position in BCAB in Q1 2021 and has held it in 21 quarters since. The position peaked at $15.8M in Q2 2021. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

Deutsche Bank held 10,507 shares of BioAtla worth $84.1K as of Q1 2026.
Deutsche Bank left its BioAtla share count unchanged in Q1 2026.
BioAtla made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3334 holding.
Deutsche Bank first reported a position in BioAtla in Q1 2021 and has held it in 21 quarters since.
Deutsche Bank's BioAtla position peaked at $15.8M in Q2 2021.
36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.